Getting Started with HALO AI
5 March 2026 | Learn how to develop your own AI algorithms for segmentation, classification, and more using HALO AI
Getting Started with HALO AI Read More »
News
Indica Labs’ Frankfurt HALO® User Group Meeting 2026
17 March 2026 | Indica Labs is pleased to announce our Frankfurt HALO® User Group Meeting at The Hilton Frankfurt Airport on 17 March from 11:00 – 16:00.
Indica Labs’ Frankfurt HALO® User Group Meeting 2026 Read More »
Looking Back: Reviewing 2025 at Indica Labs
As we reach the end of 2025, the Indica Labs team extends our sincere thanks to the customers and collaborators who helped make this year one of remarkable innovation, growth, and scientific achievement.
Looking Back: Reviewing 2025 at Indica Labs Read More »
Indica Labs Reports 260% Clinical Revenue Growth and Expansion into New Global Markets
Albuquerque, NM, December 17, 2025 – Indica Labs, the global leader in AI-powered digital pathology, announced today that clinical revenue growth rate for HALO AP® is up 260% since 2023 and recurring revenue for 2025 shows a 200% increase year-over-year, reinforcing its position as a market leader in digital pathology diagnostics.
Indica Labs Reports 260% Clinical Revenue Growth and Expansion into New Global Markets Read More »
Designing and Developing Automated Solutions Using the HALO GraphQL API
19 February 2026 | Learn the fundamentals of the HALO GraphQL API and how to design, develop, and implement time-saving automations
Designing and Developing Automated Solutions Using the HALO GraphQL API Read More »
Highly multiplexed imaging reveals CAF-immune cell niches in cutaneous carcinomas
22 January 2026 | Learn how HALO and HALO AI are helping expand our understanding of immune regulation by different subtypes of cancer-associated fibroblasts!
Highly multiplexed imaging reveals CAF-immune cell niches in cutaneous carcinomas Read More »
Advancing Neuroscience Research with HALO® and HALO AI
As scientists work to continue unraveling the structural, cellular, and molecular complexities of the brain and its diseases, the characteristics of this unique tissue pose significant challenges to traditional histological analysis.
Advancing Neuroscience Research with HALO® and HALO AI Read More »
Announcing HALO® Muscle Fiber BF and Muscle Fiber FL Modules Supporting AI-Powered Segmentation and Interactive Markups
We’re excited to announce the launch of the newly updated Muscle Fiber BF and Muscle Fiber FL modules supporting AI nuclear segmentation, AI membrane segmentation, interactive markups, and new output metrics..
Indica Labs Receives FDA Clearance for Enterprise Digital Pathology Platform with Industry Leading DICOM-Compatible Aperio Scanner from Leica Biosystems
ALBUQUERQUE, NM, and VISTA, CA, December 3, 2025 – Indica Labs, the global leader of AI-powered digital pathology, and Leica Biosystems, a global leader in anatomic and digital pathology solutions, announced today that the Food and Drug Administration (FDA) has issued a 510(k) clearance for the enterprise digital pathology platform HALO AP Dx in conjunction with Leica Biosystems Aperio GT 450 DX Scanner for in-vitro diagnostic use.
